The state of Mississippi is set to receive a portion of a nationwide $102.5 million settlement with the maker of Suboxone, Indivior Inc.
Out of the 42-state coalition, Mississippi is expected to be granted a total of $1.1 million from the settlement.
In 2016, the coalition filed a complaint against Indivior Inc. alleging that it used illegal means to switch the Suboxone market from tablets to film while attempting to destroy the market for tablets in order to preserve its drug monopoly. Suboxone is one of the main treatments for opioid addiction.
“With an opioid crisis facing our nation, we expect everyone to do their part to fight this deadly epidemic,” Attorney General Lynn Fitch said. “Indivior’s anti-competitive practices blocked the availability of cheaper generic drugs for individuals trying to break free of their dependence on opioids.”
In addition to paying the settlement funds, Indivior is also required to comply with negotiated injunctive terms that include disclosures to the states of all citizen petitions to the FDA, the introduction of new products, and if there is a change in corporate control, which will help the states ensure that Indivior refrains from engaging in the same kind of conduct alleged in the complaint.
Mississippi joins the attorneys general in the following states: Alabama, Alaska, Arkansas, California, Colorado, District of Columbia, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Hampshire, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
